Microdosing, which means taking a medication at a dose smaller than the approved dose, is not FDA-approved, but has gained traction on social media, in wellness circles, and now, in clinical conversations
Additionally, an increasing number of studies are showing positive cardiovascular outcomes in blood pressure, dyslipidemia, and biomarkers in patients treated with GLP-1RAs [59,60,61,62,63,64]
Key contraindications and poor candidate scenarios include: Men with significant cardiovascular disease or uncontrolled hypertension as mentioned, the transient BP increase is not suitable for those with serious heart conditions
However, as a substance or treatment option, Glutathione is not approved by the FDA